U.S. Bioscience's P2P Acquisition

U.S. Bioscience raised a round of funding on September 23, 1999. Investors include MedImmune.

U.S. Bioscience, based in West Conshohocken, Pa., is developing drugs to treat cancer and AIDS.…

Articles about U.S. Bioscience's P2P Acquisition: